Patients must go to one of five trial sites for their every other week enzyme infusions: Copenhagen Denmark, Paris France, Tübingen Germany, Sydney Australia, or Porto Alegre Brazil.
患者必須到五個試驗地點之一進行每間隔一周的酶注射：丹麥哥本哈根，法國巴黎，德國蒂宾根，澳大利亞悉尼，或巴西阿雷格里港。